The medication from heartburn :: Consumers survey results of for 1 quarter of 2010

Consumers survey results of for 1 quarter of 2010 in category

Digestive system and hepatology / The medication from heartburn

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Rennie (Bayer)	41.18%	5

2.	7	Гастромакс (Mili Healthcare)	32.35%	3.93

3.		Алмагель (Balkanpharma)	20.59%	2.50

4.	3	Maalox (Sanofi)	17.65%	2.14

5.		Motilium (Johnson & Johnson)	14.71%	1.79

6.		Белалгін (Борщагівський ХФЗ)	8.82%	1.07

6.	2	Гастал (Pliva)	8.82%	1.07

8.	4	Phosphalugel (Astellas Europe)	5.88%	0.71

8.	~	Домперидон Гексал (Sandoz)	5.88%	0.71

10.	7	Gaviscon (Гавіскон)	2.94%	0.36

10.	~	Домідон (Farmak)	2.94%	0.36

10.	~	Мотинол (Pharmascience)	2.94%	0.36

10.	~	Моторикс (Київський вітамінний завод)	2.94%	0.36

10.	~	Периліум (Genom Biotech)	2.94%	0.36

10.	~	Тальцид (Bayer)	2.94%	0.36

–.	7	Домперидон-Стома (Стома)	0.00%	0

–.		Домрід (Kusum Pharm)	0.00%	0

–.		Ланзап (Dr. Reddy’s)	0.00%	0

–.	7	Манті (EU Pharmacia)	0.00%	0

–.	7	Ранигаст (Polpharma S.A.)	0.00%	0

–.		~~Перидон (Лекхім)~~	~~0.00%~~	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2010, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.